Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lansoprazole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102225909B reveals a one-step POCl3 method for 2-chloromethyl-3-methyl-4-trifluoroethoxypyridine, offering significant cost and efficiency advantages for API manufacturers.
Patent CN104177336A details efficient asymmetric oxidation for Dexlansoprazole. Achieve high optical purity and cost reduction in pharma manufacturing.
Patent CN106478600A ensures 99.9% purity Lansoprazole. Stable crystal form A. Cost-effective supply chain solution for global pharmaceutical manufacturers seeking reliable partners.
Patent CN1839127A details a cost-effective NaOCl oxidation process for PPIs like Pantoprazole, minimizing sulfone impurities and ensuring high purity for commercial scale-up.
Novel process for dexlansoprazole via trifluoroethanol substitution improves purity and scalability for API manufacturing supply chains.
Patent CN102603714B details a high-yield asymmetric oxidation method for PPI intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN101323609A details a novel asymmetric oxidation method for high-purity PPI intermediates, offering significant cost reduction and supply chain reliability.
Patent CN103694225A reveals a stable titanium catalyst ligand for high-yield dexlansoprazole synthesis, offering significant cost reduction and supply reliability for API manufacturing.
Patent CN106928191B reveals improved Lansoprazole production with higher purity and yield. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103408532A details a green oxidation method for PPIs using ion exchange resin and hydrogen peroxide, offering high purity and scalable manufacturing advantages.